Harborside Inc. Announces C$20 Million Private Placement of Equity Units and Provides 2021 Outlook
Strong Institutional Support with Lead Order from Entourage Effect Capital to Support 2021 Financial Targets
OAKLAND, Calif. and TORONTO, Jan. 19, 2021 /CNW/ – Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, today announced a brokered private placement of units (the “Units”) of the Company (the “Offering”) at a price of C$2.55 per SVS Unit (as defined below) for gross proceeds of approximately C$20 million with approximately C$9.0 million of commitment from Entourage Effect Capital, LLC (“Entourage”), one of the largest shareholders of Harborside.
The Company has granted the Agents (as defined below) an option to sell up to an additional 15% of the Units in the Offering, exercisable in whole or in part at any time prior to closing of the Offering.
Each Unit issued to non-residents of the United States (an “SVS Unit”) will be comprised of one subordinate voting share of the Company (the “Subordinate Voting Shares”) and one Subordinate Voting Share purchase warrant (each a “Warrant”) of the Company. Each Warrant will be exercisable to acquire one Subordinate Voting Share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering (the “Closing Date”) at an exercise price of C$3.69 per Warrant Share, subject to adjustment and acceleration in certain events.
All investors that are considered residents of the United States under the United States Securities Exchange Act of 1934, will be issued units comprised of multiple voting shares of the Company (the “Multiple Voting Shares”) and Multiple Voting Share purchase warrants of the Company, which will be based on the same economic equivalency of each Multiple Voting Share converting into 100 Subordinate Voting Shares.
We are continuing to expand our footprint in the robust California cannabis market, delivering our best-in-class service and the high-quality product selection that Harborside is known for. California is one of the largest cannabis markets in the world and Harborside has more than a decade of market success for our team to build on.
Matthew Hawkins, Chairman of Harborside
I would like to thank our current and new shareholders for their overwhelming support of our growth strategy. This additional capital will solidify our balance sheet and provide a platform for us to continue to consolidate in the California market through accretive M&A transactions.
The Company expects to use the net proceeds from the Offering for general corporate and working capital purposes.
ATB Capital Markets and Beacon Securities Limited will act as co-lead agents to the Offering (the “Agents”). The Company has agreed to pay the Agents a cash commission payable on the Closing Date equal to 6.0% of the aggregate gross proceeds of the Offering (the “Cash Commission”), and to issue the Agents warrants (the “Broker Warrants”), exercisable to acquire, within 12 months from the Closing Date, in the aggregate, that number of Subordinate Voting Shares (the “Broker Warrant Shares”) that is equal to 6.0% of the aggregate number of Units sold in the Offering, at an exercise price of C$2.55 per Broker Warrant Share. An adjusted commission structure will apply on select president’s list investors coordinated by the Company. Subject to customary closing conditions, including applicable CSE approvals, the Offering is expected close on or about February 9, 2021 (the “Closing Date”), or such other date as the Company and the Agents may agree.
As certain insiders and other related parties of the Company will be participating in the Offering, it is deemed to be a “related party transaction” as defined under Multilateral Instrument 61-101—Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Offering is exempt from the formal valuation and minority shareholder approval requirements of MI 61- 101 (pursuant to subsections 5.5(a) and 5.7(a)) as the fair market value of the securities distributed to, and the consideration received from, related parties will not exceed 25% of the Company’s market capitalization.
2020 Preliminary Results and 2021 Outlook¹ ²
The Company is also pleased to provide the following update of guidance for 2020 along with guidance for 2021.
For the full year ended 2020, the Company is expecting gross revenues in line with previously issued guidance of approximately $61 – 63 million, and positive EBITDA. For the full year ended 2021, the Company expects standalone gross revenues of between $68 – $72 million. The increase in revenues for 2021 is expected to be derived from improved pricing in retail along with continued increases in both flower yields and processing efficiencies in Harborside’s wholesale operations. As well, the Company expects a 2021 full year of Adjusted EBITDA³ in the range of 15 – 17% of revenues, compared to the previously disclosed 2020 expectation of Adjusted EBITDA³ in the range of 8 – 10% of revenues. Management expects to attain this higher level of Adjusted EBITDA³ in 2021 through more efficient procurement of goods sold and stronger cost discipline on overhead spend.
Intention to Divest of Oregon Assets¹
Through a review of the Company’s existing retail portfolio, management has decided to explore the divestiture of its one retail dispensary operating as Terpene Station in Eugene, Oregon (the “Oregon Assets”) as part of the Company’s continued efforts to focus on the California market. The Company has not entered into any agreements, binding or non-binding, to divest of the Oregon Assets as of this date. Further, the Company has not established a definitive timeline to complete such divestiture, and no decisions related to the divestiture have been reached at this time. There can be no assurance as to what, if any, transaction might be pursued by the Company as a result of its intention to divest the Oregon Assets. The Company does not intend to comment further with respect to the divestiture unless and until it determines that additional disclosure is appropriate in the circumstances and in accordance with the requirements of applicable securities laws.
For the latest news, activities, and media coverage, please visit the Harborside corporate website at http://www.investharborside.com or connect with us on LinkedIn, Facebook, and Twitter.
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.
About Entourage Effect Capital:
Entourage Effect Capital, LLC, formerly known as Cresco Capital Partners, LLC, is a United States private investment firm, dedicated to investing in the cannabis industry. The firm’s mission is to actively leverage its sector and investment experience, networks, and investment process, and to identify, invest and accelerate high quality emerging growth companies. Entourage was formed in 2014 and is based in Dallas, Texas.
Non-IFRS Measures, Reconciliation and Discussion
This press release may contain references to “Adjusted EBITDA”, which is a non-IFRS financial measures.
Adjusted EBITDA is a measure of the Company’s overall financial performance and is used as an alternative to earnings or net income in some circumstances. Adjusted EBITDA is essentially net income (loss) with interest, taxes, depreciation and amortization, non-cash adjustments and other unusual items added back. This measure can be used to analyze and compare profitability among companies and industries, as it eliminates the effects of financing and capital expenditures. It is often used in valuation ratios and can be compared to enterprise value and revenue. This measure does not have any standardized meaning according to IFRS and therefore may not be comparable to similar measures presented by other companies.
There are no comparable IFRS financial measures presented in Harborside’s financial statements. Reconciliations of the supplemental non-IFRS measures are presented in the Company’s management’s discussion and analysis for September 30, 2020. These non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believes that the non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. The Company believes that these supplemental measures provide information which is useful to shareholders and investors in understanding our performance and may assist in the evaluation of the Company’s business relative to that of its peers.
These non-IFRS financial measures should not be considered superior to, as a substitute for, or as an alternative to, and should be considered in conjunction with, the IFRS financial measures presented in the Company’s financial statements. For more information, please see “Use of Non-IFRS Measures” and “Non-IFRS Measures” in the Company’s management’s discussion and analysis for September 30, 2020, which is available under the Company’s profile on www.sedar.com.
¹This is forward-looking information and based on a number of assumptions. See “Cautionary Note Regarding Forward-Looking Information”.
²These targets, and the related assumptions, involve known and unknown risks and uncertainties that may cause actual results to differ materially. While Harborside believes there is a reasonable basis for these targets, such targets may not be met. These targets represent forward-looking information. Actual results may vary and differ materially from the targets. See “Cautionary Note Regarding Forward-Looking Information” and “Assumptions” below.
³This is a non-IFRS reporting measure. For a reconciliation of this to the nearest IFRS measure, see “Use of Non- IFRS Measures” and “Non-IFRS Measures” in the Company’s management discussion and analysis for September 30, 2020.
For fact-based information on The Harborside Group, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.
Sunnyvale – #1 CBD Gummies & How to use It?
The endocannabinoid system (ECS) regulates everything from relaxation to eating, sleeping, inflammation and even cognitive function. In a nutshell, the ECS is responsible for making sure the entire body is working optimally. Sunnyvale Labs CBD Gummies has been shown to positively regulate your ECS addressing issues such as anxiety, insomnia, chronic pain, and inflammation. Here is what the ECS system is known to do:
Body: Stimulates an anti-inflammatory response which helps reduce all forms of chronic aches and pains. Regular use also helps support joint health, mobility, and flexibility.
Brain: Helps positively regulate mood patterns which help reduce anxiety and stress. It also promotes better sleep cycles and in some cases may offer a safe remedy for depression and bipolar disorders.
Age: Inflammation is a natural killer responsible for all sorts of disease such as diabetes, heart disease, cancer, and more. Inflammation is also a positive mechanism used to heal damaged tissue. The ECS is a critical part of managing the parts of the body that when finely tuned can help you feel you.
Sunnyvale Labs CBD Gummies — Instant Pain Relief Hemp Gummies!
Sunnyvale Labs CBD Gummies: One of the incredible matters generally this thing is that it’s so multi-reason. For example, when you have pulsated again, this could assist you with diminishing that without hurt killers. Or on the other hand, when you have a strain that returns with your total perception around night time, the local Sunnyvale Labs CBD Gummies Ingredients license you to calm down, too.
What Are The Sunnyvale Labs CBD Gummies Ingredients?
The Sunnyvale Labs CBD Gummies Ingredients include effective, local portions to help you fix your extra health! This first-rate mix comes directly from the hemp plant with the objective that you may be ensured which you are transforming into your first-rate recuperation. Also, the portions are each 100% characteristic and absolutely THC-FREE! This fundamentally pushes toward that this incredible hemp Gummies awards you to repair without a point of view results.
What Is The Sunnyvale Labs CBD Gummies Price?
You can declare the base Sunnyvale Labs CBD Gummies Cost by clicking any photograph or catch on this page! Our hyperlinks will dispatch you to direct to the peak propelling hemp Gummies so you can discover first-rate deals. If your surge, you may even report FREE hemp Gummies together close by your acquisition of the summit propelling tone!
Where To Buy Sunnyvale Labs CBD Gummies
On the off chance that you’re everything viewed as contemplating in which to buy Sunnyvale Labs Hemp Gummies, you may discover it at the substantial thing site! Else, you may tap on any photograph or catch on this site page to look at what phenomenal gives are open. If your surge, you may even articulate a FREE shading together close by your acquisition of the apex propelling hemp Gummies! With this first-rate deal, you may get your first honor for a part of the genuine cost.
Pet CBD(cannabidiol) Market to See Booming Growth | Canna-Pet, Choom Holdings, Receptra …
Pet CBD(cannabidiol) Market research Report is a valuable supply of perceptive information for business strategists. This Pet CBD(cannabidiol) Market study provides comprehensive data which enlarge the understanding, scope and application of this report.
A specific study of competitive landscape of the global Pet CBD(cannabidiol) Market has alloted, providing insights into the corporate profiles, financial standing, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provides a transparent plan to readers concern regarding the general market situation to further choose on this market projects.
The Pet CBD(cannabidiol) Market report profiles the following companies, which includes: – Canna-Pet, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum, Cannabis Strategies Acquisition, Pet Releaf, Diamond CBD, PotNetwork Holdings, Kat’s Naturals, Bluebird Botanicals
Get Sample Copy of this Report @ https://www.reportsintellect.com/sample-request/1241443
This report studies the global Pet CBD(cannabidiol) Market status and forecast, categorizes the global Pet CBD(cannabidiol) Market size (value & volume), revenue (Million USD), product price by manufacturers, type, application, and region. Pet CBD(cannabidiol) Market Report by Material, Application and Geography with Global Forecast to 2025 is an connoisseur and far-reaching research provide details related to world’s major provincial economic situations, Concentrating on the principle districts (North America, South America Europe, and Asia-Pacific) and the crucial nations (United States, Germany, United Kingdom, Japan, South Korea, and China).
By Types: CBD Capsule, CBD Oil, CBD Jelly
By Applications: Pets Gastrointestinal Diseases, Pet Sleep Disorder, Pet Anxiety
Market Segment by Regions, regional analysis covers
Middle East and Africa
Table of Contents –
Global Pet CBD(cannabidiol) Market Size, Status and Forecast 2025
1 Market Overview
2 Manufacturers Profiles
3 Global Pet CBD(cannabidiol) Sales, Revenue, Market Share and Competition by Manufacturer
4 Global Pet CBD(cannabidiol) Market Analysis by Regions
5 North America Pet CBD(cannabidiol) by Countries
6 Europe Pet CBD(cannabidiol) by Countries
7 Asia-Pacific Pet CBD(cannabidiol) by Countries
8 South America Pet CBD(cannabidiol) by Countries
9 Middle East and Africa Pet CBD(cannabidiol) by Countries
10 Global Pet CBD(cannabidiol) Market Segment by Type
11 Global Pet CBD(cannabidiol) Market Segment by Application
12 Pet CBD(cannabidiol) Market Forecast
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
Get a Good Amount of Discount @ https://www.reportsintellect.com/discount-request/1241443
Overview of the chapters analysing the global Pet CBD(cannabidiol) Market in detail:
- Chapter 1 details the information relating to Pet CBD(cannabidiol) introduction, Scope of the product, market overview, Market risks, driving forces of the market, etc
- Chapter 2 analyses the top manufacturers of the Pet CBD(cannabidiol) Market by sales, revenue etc for the Forecast period 2020 to 2025
- Chapter 3 analyze on the competition landscape amongst the highest manufacturers based on sales, revenue, market share etc for the period 2020 to 2025.
- Chapter 4 defines the globalmarket by regions and their market share, sales, revenue etc for the period to 2025.
- Chapters 5 to 9 analyse the Pet CBD(cannabidiol) regions with Pet CBD(cannabidiol) countries based on market share, revenue, sales etc.
- Chapter 10 and 11 contain the knowledge concerning market basis types and application, sales market share, rate of growth etc for forecast period 2020 to 2025.
- Chapter 12 focuses on the market forecast for 2020 to 2025for the Pet CBD(cannabidiol) Market by regions, type and application, sales and revenue.
- Chapter 13 to 15 contain the transient details associate to sales channels, suppliers, traders, dealers, research findings and conclusion etc for the Pet CBD(cannabidiol) Market.
Reasons why you should buy this report
- Understand the current and future of the Pet CBD(cannabidiol) Market in both developed and emerging markets.
- The report assists in realigning the business strategies by highlighting the Pet CBD(cannabidiol) business priorities.
- The report throws light on the segment expected to dominate the Pet CBD(cannabidiol) industry and market.
- Forecasts the regions expected to perceive ascension.
- The newest developments within the Pet CBD(cannabidiol) industry and details of the industry leaders along side their market share and methods.
- Saves time on the entry level research as the report contains important data concerning about growth, size, leading players and segments of the industry.
- Save and cut time carrying out entry-level research by distinguishing the growth, size, leading players and segments within the global Market.
Reports Intellect is your one-stop solution for everything associated with marketing research and market intelligence. We tend to perceive importance of market intelligence and its need in today’s competitive world.
Our exhausting team works hard to fetch the foremost authentic research reports backed with impeccable data figures that guarantee outstanding results anytime for you.
So, whether it’s the newest report from the researchers or a custom requirement, our team is here to assist you within the absolute best way.
PH – + 1-706-996-2486
225 Peachtree Street NE,
Atlanta, GA 30303
Florida Bill Aims to Legalize Medical Magic Mushrooms
Nanocrystallization of a Ti40 cladding layer by ultrasonic impact to improve burn resistance
Delta 8: Shipping Vape Ban Goes Into Effect Soon – What Does It Means?
Explained: How CBD Oil is Different Than CBD Capsule?
Investigation of severe lunar environmental conditions on the physical and mechanical properties of lunar regolith geopolymers
Affordable cbd oil?
Wear behavior of nanostructured carbo-austempered cast steels under rolling-sliding conditions
Local Turkish DKP grade scrap prices remain stable
Friction resistance and bonding strength of high vanadium alloy steel/low carbon steel bimetal after heat treatments
Dielectric properties and potential applications of alizarin yellow GG-Cu(II) complex film blended with polyvinyl alcohol
Chemical attack and corrosion resistance of concrete prepared with electrolyzed water
Effect of Al content on the high-temperature oxidation behavior of 18Cr–Al–Si ferritic heat-resistant stainless steel
A new approach to study combination mixture organic solvent ethylene carbonate with lithium-ion for alkali-ion battery: A density functional theory
Perfect harmony blended with an inked soul, Craig Cavanagh to create sensations in the mind
What can I use besides injection moulding?
A method for estimating superplastic material parameters via free–inflation tests
Unnamed Company Tried to Buy Aphria While It Was Negotiating Tilray Merger
Growth kinetics of the FeB/Fe2B boride layer on the surface of 4Cr5MoSiV1 steel: experiments and modelling
Competitive mechanisms occurring during quenching and partitioning of three silicon variants of 0.4 wt.% carbon steels
Making a Yellow Taxi Toplight
Correlative cross-sectional characterization of nitrided, carburized and shot-peened steels: synchrotron micro-X-ray diffraction analysis of stress, microstructure and phase gradients
Influence of heavy metal oxides to the mechanical and radiation shielding properties of borate and silica glass system
CBD and Inflammation
Bermuda Prepares To Lock Horns With United Kingdom Over Adult Use Cannabis
How Will Global Cannabidiol Products (CBD Products) Market React from 2021 Onwards?
Fatigue rate evaluation of a transparent polyester resin subjected to low-temperature environments
Efficacy of CBD Edibles
Activated carbon electrode with promising specific capacitance based on potassium bromide redox additive electrolyte for supercapacitor application
Heartland1 week ago
Will California Really Ban Smokable Hemp?
Heartland1 week ago
How do I make my own isolate cartridges?
Heartland1 week ago
CBD For Glioblastoma
Heartland1 week ago
Effective determination of the principal non-psychoactive cannabinoids in fiber-type Cannabis sativa L. by UPLC-PDA following a comprehensive design and optimization of extraction methodology
Heartland1 week ago
Biochemical aspects of seeds from Cannabis sativa L. plants grown in a mountain environment
Heartland1 week ago
Humboldt County, California, permanently bans hemp cultivation
Heartland1 week ago
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Heartland1 week ago
CBD Oil Recommendations for Autism and ADHD (UK)?